In the version of this article initially published, the Thrombogenics drug Jetrea (recombinant microplasmin) was listed in “Notable upcoming regulatory decisions” as indicated for thyroid cancer. It should have read vitreomacular adhesion. The error has been corrected in the HMTL and PDF versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nbt.2359
Rights and permissions
About this article
Cite this article
DeFrancesco, L. Erratum: Drug pipeline: Q212. Nat Biotechnol 30, 1249 (2012). https://doi.org/10.1038/nbt1212-1249d
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1212-1249d
